Pharma Boardroom for the coverage: Little Fish, Big Pond-Growing a Taiwanese Medtech Startup Internationally

Thank you Pharma Boardroom for the coverage!

” iXensor is devoted to leveraging the power of Point-of-Care (POC) diagnostics to provide a comprehensive mobile health solution across a variety of essential health areas. “We originally started iXensor in glucose management exclusively. However, with our technology platform, we were able to expand our offering and allow consumers to use their smartphone to test for several different biomarkers,” explains Carson Chen, the company’s co-founder and chief technology officer (CTO).

Alan Tsai, iXensor’s other co-founder and general manager adds, “Currently, our technology platform covers three areas: chronic disease, women’s health, and infectious disease.” With this platform, patients and healthcare professionals can monitor ovulation cycles, blood sugar levels, and conduct rapid tests of transmittable diseases, such as zika and dengue with the same device.”

See full story: